MMD is a fully integrated subsidiary of Medpace, providing sponsors with the access to Medpace therapeutic and executive level expertise, core lab and imaging services, enhanced safety management services and global infrastructure. This further enhances MMD’s leadership position as a best-in-class CRO for the design and execution of medical device trials.
The management team will remain in place, and the main offices for MMD will remain in Minneapolis with the added flexibility to consult and conduct device trials on a global basis as a member of the Medpace group of companies.
"Through this integration we believe we offer our customers something completely different and unique true medical device expertise with a comprehensive and global service offering through one provider," said Ryan Wilson, General Manager, Medpace Medical Device. "This allows us to have tighter control over project timelines and make the outsourcing experience more seamless for our customers."
MMD, formerly Symbios was acquired by Medpace in March 2010. Over the last seven months, the Medpace and MMD teams have worked to integrate functions for both companies. The result will greatly expand MMD’s service offering and enhance its capabilities for its customers, as well as strengthen Medpace capabilities overall.